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Background: Cigarette smoking remains the leading preventable cause of death and disease. Thus, all activities
aiming to reduce smoking play an important role in improving population health. The positive role of the general
practitioner (GP) in smoking cessation could increase the success rate for quitting smoking, if compared with
unassisted cessation. The aim of this study was to determine what kind of general practitioner smokers need in
order to stop smoking.
Methods: Four focus groups with 12 current and 12 former smokers (aged 20-59, 11 women and 13 men), were
arranged in the city of Toruń, Poland, with a view to describe their opinions on the GP’s role in smoking cessation.
The data were subjected to descriptive qualitative content analysis.
Results: Two major themes emerged in the analysis: the smokers’ positive and negative experiences of the GP in
smoking cessation and their expectations regarding the role of the GP in smoking cessation. The first theme
embraced the following subthemes: (1) GP’s passivity, (2) routine questions about the patient’s smoking during the
visit, (3) lack of time during the visit, and (4) the role model of the GP in smoking cessation. Within the second
theme, the respondents identified the following subthemes: (1) bringing up the topic of smoking cessation, even in
situations when the patient is unprepared for this; (2) the necessity of a tailored approach to the patient; (3) access
to information and evidence confirming the harms of smoking tobacco; (4) prescription of pharmacological and
other treatment; and (5) referral to specialists in smoking cessation.
Conclusions: Patients expect their GP to actively participate in smoking cessation through a more tailored
approach to the patient’s needs. The patients’ experiences did not match their expectations: the smokers rarely got
advice on smoking cessation from their GPs. Finally, they emphasized the importance of the GP as a role model in
smoking cessation.
Keywords: Smoking cessation, Primary care, Qualitative researchBackground
Cigarette smoking remains the leading preventable cause
of death and disease across the world [1,2]. The World
Health Organization (WHO) estimates that globally over
one billion people smoke tobacco [3]. Furthermore, it is
estimated that 21% of cancers are due to smoking [4]
and that by 2015 smoking will be the cause of 10% of all
deaths [5]. The WHO also attributes approximately six* Correspondence: buczkowskik@cm.umk.pl
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distribution, and reproduction in any mediummillion deaths per year to tobacco, and this is expected
to rise to around ten million per year by 2030 [6].
Smokers now represent close to 29% of the adult
population in Poland [7]. But in the past consumption of
cigarettes, especially in the 1970s and 1980s, was one of
the highest in the world, reaching approximately 3600
cigarettes per adult [8]. Since the mid-1990s, the sale
and consumption of cigarettes have declined.
Cross-sectional studies show that most smokers in
developed countries want to stop and intend to stop at
some point [9]. The increasing number of people who
want to stop smoking plays a key role in improvingtral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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to quit is one of the most cost-effective medical inter-
ventions available [10,11].
Reducing the prevalence of smoking remains one of
the most important public health goals [12,13]. To this
purpose, in 2010 Polish parliament approved Act of
Amendment of the Act on Protection of Health Against
the Consequences of Consumption of Tobacco and
Tobacco Products [14]. It introduced a ban on smoking
in public places, a ban on tobacco advertisements and
the requirement of health warning labels on tobacco
products [15]. Furthermore, the government takes ac-
tions in order to increase the price of cigarettes, which
for the most popular price category (20 cigarettes) is
currently 1,92 Euro (7,95 Polish zloty). Excise taxes total
66% of the weigthed average price [16].
Besides, many nationwide campaigns are organized to
reduce smoking, for example, World No Tobacco Day,
celebrated annually, or the international day of quitting
smoking. The Civic Coalition “Tobacco or Health”, founded
in 2003, associates a number of non-governmental organi-
zations acting locally to encourage people to stop smoking.
An example of a local initiative addressed to current
smokers is the campaign “Know the age of your lungs” held
in Torun and Bydgoszcz, which offers spirometric examin-
ation with anti-nicotine intervention.
In Poland smoking cessation interventions are admin-
istered mainly by the GP, and in the case of patients
referred for consultation – also by specialists. No gra-
tuitous stop smoking services are available in Poland. If
patients want to get help in smoking cessation in pri-
mary care, they visit their GP. However, the GP spends
most of his time treating patients, not promoting health.
Family medicine was implemented in Polish healthcare
system only 20 years ago, so its position up to this day
isn’t stable. An average GP has approximately 2500 pa-
tients at all ages on his list, consults around 40 patients
a day, and has 4 home visits [17,18]. Patients have access
to their GPs from Monday to Friday from 8.00 am to
6.00 pm. Although many GPs feel overburdened with
workload and administrative duties [19], over two-thirds
of patients feel satisfied with their GP [20].
Over the last couple of years knowledge about smok-
ing cessation has broadened considerably. Pharmaco-
logic treatments have been developed and access to
behavioral treatment improved. In addition, in many
countries there are special services which help in the
process of stopping [21]. Owing to increased knowledge
of smoking harm and public initiatives to limit smoking
more and more smokers make attempts to quit, yet in
the majority of cases these are spontaneous attempts.
The most common method of stopping smoking is still
unassisted cessation: cold turkey or reducing before quit-
ting [22,23]. These unassisted activities are effective,however, the chances of successful quitting would increase
if attempts were accompanied by pharmacotherapy or be-
havioral treatment, [24]. Unassisted quit rate is 2-3%. A
brief advice intervention can increase quitting by a further
1 to 3%. Adding nicotine replacement therapy (NRT) can
increase the rate of quitting by another 0,7-2,1% [25].
Buproprion is of similar efficacy to nicotine replacement
[26]. Varenicline increases the chances of successful long-
term smoking cessation by two- and threefold [27] and
seems to be the most effective pharmacotherapy for smo-
king cessation [28]. These various forms of pharmacothe-
rapy are available in Poland, including NRT without
prescription, but they are non-refundable.
Hence, it is essential that those who are intent on quit-
ting smoking have access to pharmacotherapy and any
form of medical help. This can be provided by GPs, es-
pecially through motivating smokers and offering smok-
ing cessation support to any smoking patient in relevant
clinical situations. The special doctor-patient relation-
ship and frequent visits may help to identify those who
ought to quit, but who do not manage on their own.
There are many international [29,30] and national
guidelines (designed, for example, by College of Family
Physicians in Poland [31]), which help GPs deal with
smoking patients. These guidelines recommend combin-
ing medication and behavioral support to help people
stop smoking. The most frequently recommended inter-
vention is the so-called “five As”: ask, advise, assess, as-
sist, and arrange. This strategy assumes that each time a
smoking patient visits the doctor the topic of smoking is
mentioned, and that the patients ready to quit are pro-
vided with help [30-32]. However, the data show that
this procedure is not widely put into practice [33,34].
This is the result of a lack of time for such intervention
during routine visits, and the fact that a structured inter-
vention is not entirely accepted by patients, who may ex-
pect from their GPs a more tailored approach [23].
The aim of this study was to explore current and
former smokers’ experiences and expectations of GPs’
help in smoking cessation in a Polish medical setting.
Methods
Descriptive qualitative analysis was used with focus group
data in order to explore the smokers’ views of their GP’s role
in smoking cessation. The method refers to Sandelowski
[35] and Lundman&Granheim [36]. This method is orien-
tated towards establishing a straight descriptive summary of
the informational contents of the data.
Design
Since our study deals with sensitive issues that require
deep discussion during the interview, which included
the respondents’ health, addiction, and doctor-patient
relationships, the qualitative method for generating data
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Focus groups were used to collect data as they encour-
age interaction amongst participants, and highlight areas
of agreement or disagreement within a group. Further-
more, the dynamics of focus group discussions could re-
veal aspects of the smoking cessation issue that were not
taken into account when we devised the topic guide
(Additional file 1). Finally, focus groups allowed us to in-
vestigate the participants’ expectations and beliefs about
the role of the GP in smoking cessation, in addition to
their experiences of quitting.Participants, setting and data collection
Purposive samples of patients for focus groups were
recruited through advertisements disseminated at the
Institute of Sociology of Nicolaus Copernicus University
in Torun (EP) and two general practices in Bydgoszcz
and in Torun, Poland (KB and SC). The advertisement at
the Institute of Sociology was addressed to everyone will-
ing to participate in the study, irrespective of their age or
student status. Advertisements for the research project
were also placed in the practices, which together provide
medical services to around 15000 patients. In addition,
patients were informed about the opportunity to partici-
pate in the project by their GP or nurse. The study was
conducted between December 2009 and March 2010.
Four focus groups with a sample of 24 patients (12
current and 12 former smokers) were arranged: two
groups of current smokers and two of former smokers.
During the recruitment process, the smoking status
was defined according to the WHO criteria [37,38]. A
patient who had been smoking for at least six months
and was a smoker at the time of the study was defined
as a current smoker. A person who had smoked for at
least six months, and who hadn’t smoked for at least
three months prior to when the study was conducted,
was regarded as a former smoker. The smokers also had
to be 18 years old or older.
After the third focus group, data saturation was
achieved. Data saturation refers here to the point at
which additional interviews do not provide any new in-
sights into the topic. As one more focus group was
already arranged, we elected to continue data collection
with this last group.
Eleven women and thirteen men, aged 20–59, partici-
pated in the study. The mean age of the participants was
38 years old. The average duration of smoking was about
16 years (range 1–35 years). It was slightly shorter in
women (13 years) than in men (almost 17 years). Smok-
ing status and participants’ characteristics are presented
in Table 1. While presenting the results, we use the
numbers of participants and so, for example, P2 stands
for Participant number 2.Discussions were moderated by an experienced facili-
tator (EP) according to the topic guide derived from the
literature, which was adjusted after pilot discussions with
two current and former smokers who were excluded
from the study. The focus group discussions lasted from
60 to 90 minutes. All discussions were tape-recorded
and transcribed verbatim.
Data analysis
The focus group interviews, in the form of recordings
and transcriptions, were analysed by a multidisciplinary
team (researcher, physician, sociologist, linguist).
Three authors (KB, LM and AS) read the transcripts
of focus group interviews to obtain a sense of the whole
and become familiar with each focus group interview.
Meaning units which described the smokers’ experiences
and perception of their GPs’ actions in smoking cessa-
tion were next identified, condensed and independently
labeled with various codes to express a general under-
standing of them (Table 2). During the analysis the au-
thors stayed close to the data and the surface of words
and events, paying attention to recurring regularities and
the words that appeared to capture key thoughts The
various codes were subsequently compared and formu-
lated into subthemes and themes, after discussion with
other researchers (EP and SC). Two major themes
emerged during the analysis, which are described in the
following section. Selected quotations, which reflect the
smokers’ most typical answers, were then translated into
English by the linguist (AS).
Ethical considerations
Ethical approval was granted by the Bioethical Commit-
tee of the Collegium Medicum at Nicolaus Copernicus
University, Bydgoszcz, Poland. Potential participants
were provided with information about the study, and
those who decided to participate gave an informed con-
sent. Confidentiality was assured and anonymity of the
smokers was protected.
Results
The analysis of the transcripts revealed that the patients’
experiences of their GPs’ behavior were predominantly
negative, and resulted either from the GP’s bad practices
or the shortcomings in the Polish primary care system.
They were divided into the following subthemes: (1)
GP’s passivity, (2) routine questions about the patient’s
smoking during the visit, (3) lack of time during the visit
and, finally, (4) the role model of the GP in smoking
cessation.
The experiences show that anti-smoking intervention
was rarely undertaken by the GP, and if it was, the GP
was not much engaged. The participants appreciated a
tailor-made approach, which was evident in their
Table 1 Focus group characteristics






1 1 20 F C 3
2 1 29 F C 10
3 1 35 F C 20
4 1 53 M C 25–30
5 1 21 M C 6
6 1 43 F C 27
7 2 24 M C 1
8 2 43 F C -
9 2 52 M C 35
10 2 21 F C 4
11 2 26 M C 11
12 2 33 F C 17
13 3 43 M F 11
14 3 31 M F 13
15 3 28 F F 8
16 3 57 M F 15
17 3 30 F F 13
18 3 57 F F 15
19 3 42 M F 15
20 4 48 M F 30
21 4 40 F F 13
22 4 28 M F 12
23 4 49 M F 30
24 4 59 M F 20
C – current smoker.
F – former smoker.
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cessation.
Patients’ experiences of their GP’s actions in quitting
smoking
GP’s passivity
Although the patients differed in their experiences,
many of them admitted that their GP had never raised
the issue of smoking. This stands in stark contrast to the
patients’ expectations. The experience of the GP’s passiv-
ity was commonplace and is illustrated by the formerTable 2 Example of meaning unit, condensed meaning unit, i
analysis
Meaning Unit Condensed meaning unit,
description close to the te
“[The GP] should treat everyone individually, be
able to relate to the patient’s disorders because
we wouldn’t care about something that is
routine.
Should treat everyone
individually, relate to the
patient’s disorders, patients
don’t care for routinesmokers who succeeded in quitting smoking, even
though their GP did not motivate them to do it, neither
did he participate in the other stages of smoking
cessation.
“So far I haven’t met a doctor who would ever mention
smoking, never…” (P13)
“As a patient, I’ve never met with this… that the
doctor asked about smoking…” (P21)
These examples indicate that Polish GPs often ignore
the problem of smoking during the consultation. Pa-
tients do not evaluate this behavior positively. They
think that prevention should be part and parcel of the
consultation.
“I agree that the GP should help in smoking cessation,
explain and answer questions, but should do it out of
his own will, and not because I visit him especially
and only for this (P17).”
In sum, for various reasons lack of questions about
smoking during the consultation was not met with pa-
tients’ content.
Routine questions
In the few cases where the GP did intervene, the patients
drew attention to the doctor’s routine questions, which
lacked a personal touch. This behavior had no motivat-
ing effect on the smokers and did not encourage them
to seek help with their GP. The following examples cor-
roborate this:
“The GP asked me about smoking during the periodic
check-up. When I admitted to it, he asked how many,
20, give it up, give it up, and nothing more.” (P 19)
According to the respondents, the GP’s routine behav-
ior caused disappointment and from the perspective of
anti-nicotine interventions it was a missed opportunity
for building motivation. Likewise, the next example
shows that routine questions without any particular in-
formation tailored to the patient’s needs and expecta-
tions are not welcome by patients, even though thenterpretation, subthemes and themes from content
xt
Interpretation (Code) Subtheme Theme
The necessity of an individual
approach to the patient, lack of
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the consultation.
“When I go to the doctor, he also asks me if I smoke or
if I’m planning to quit. So routinely… and he says that
I should stop smoking, but nothing specific has he told
me so far, only to stop smoking… that smoking is
harmful, and all that jazz… generally…” (P4)
Lack of time during the visit
The respondents pointed to haste and a lack of time to
bring up the problem of smoking during the visit as
some of the possible causes of lack of GP intervention.
Many of the investigated patients noticed that the GP
barely had time to resolve basic medical problems. Only
a few patients admitted to talking with their GP about
quitting smoking, even though the promotion of a
healthy lifestyle, if necessary through anti-nicotine inter-
vention, should be a responsibility that lies with the GP.
“Doctors don’t start the topic of smoking… they are
constantly in a hurry… They’ve got only a moment for
the patient, done, and next please, next…” (P8)
“Frankly speaking, the GP doesn’t necessarily have
time for this [to make people aware of the harms of
smoking] because we know what’s going on, for
example, in the [flu] season… I often go because I’ve
got kids, they are ill, and I know what queues there
are, how long one sometimes has to wait…” (P3)
According to the respondents, it was precisely lack of
time that was a major cause of missing anti-nicotine in-
terventions or other actions during the consultation
which did not meet their expectations.
The role model of the GP in smoking cessation
What the respondents found relevant was whether their
GP used to be a smoker, if he was able himself to com-
ply with the advice he gives to his patients and, finally,
what experience he had in smoking cessation activities.
One of the most demotivating GP activities found by
some patients was their GP’s own smoking habits. Such
behavior meant that the doctor was not reliable when
encouraging the patient to quit. The belief held by the
patients was that, if the GP was not able to help himself,
he certainly wouldn’t be able to help them.
“In my health centre, there is no GP who wouldn’t
smoke (…) And so if the GP himself smokes he will not
advise [me] to quit for health reasons” (P4)
Others mentioned the GP’s inconsistency in giving ad-
vice about smoking cessation and an indirect acceptanceof smoking, which was demotivating, according to the
respondents.
“When I was sitting in the surgery and the GP kept on
explaining that I must do this and that, and a
moment later he was saying – ‘let’s go, have a smoke’,
the motivation disappeared straightway” (P23)
Another negative experience was the smokers’ feeling
that the GP does not believe in their success of quitting.
This behavior was also regarded as a disincentive for
smoking cessation.
“She’s examined me and she’s saying: ‘You won’t quit
anyway’, but earlier she told me not to smoke, and
then she’s saying ‘You won’t give up anyway, if you’ve
been smoking for so many years’ … She didn’t even
discourage me.” (P9)
However, there were also a few positive experiences
that emerged in the discussions. Showing that smoking
cessation may also be the GP’s problem, that the GP too
had to make an effort to quit, allows the patient to look
on his doctor from a different perspective and enhances
the doctor-patient relationship. In the following excerpt
the patient points to a convincing example of the GP’s
own experience:
“And he [the GP] told me: ‘I used to smoke but freed
myself from it, and just gave up cigarettes…’; I found it
more convincing that he’d said to me: ‘and I freed
myself from it’, not from the medical point of view, but
as a human, that he went through it himself; he
impressed me.” (P3)Smokers’ expectations about the role of the GP in
smoking cessation
The smokers expressed expectations of a GP’s active role
in smoking cessation, which would involve bringing up
the topic of smoking cessation during the consultation,
adopting a tailored approach to the patient, showing re-
liable evidence on the harms of tobacco smoking and
prescribing pharmacological or other treatment. Finally,
the respondents also emphasized the importance of
other specialist services and psychological support.Bringing up the topic of smoking cessation in situations
where patients are not prepared to bring it up themselves
Most respondents clearly stressed that the GP should
initiate the topic of smoking cessation during the con-
sultation and inform them about health hazards and the
possibility of help, rather than wait until patients them-
selves ask for help. Yet, this is not to happen at every
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not smoking related.
Patients are often ashamed to admit to smoking and
find it difficult to ask the GP for help in quitting. They
assume the GP will start the topic of smoking cessation
himself, offering the patient adequate help, particularly
when they do not feel ready themselves to bring the
issue up.
“The best in my case would be if the GP asked me if I
want to give up smoking, if I smoke…, then I could
possibly ask: What is good and effective advice to quit,
Doctor? (P 6)
Some respondents were very pronounced about it and
pointed out it is not only the GP’s responsibility to touch
upon the issue of stopping smoking, but also manage
the patient in such a way as to resolve the problem.
“I think the GP is there to ask and to help. And to see
the whole patient and not just because you’ve got a
runny nose or you’re cold… the doctor should say ‘I
will manage you, come to me every week or once a
month.” (P8)
The necessity of a tailored approach to the patient
Frequently, the patients reported the need for a tailored
approach. In contrast to a routine approach, a more in-
dividualized approach that meets the patient’s needs is
conducive to the patient’s compliance and thus, in turn,
to his attempt to change a lifestyle and give up smoking.
However, according to the patients, this approach should
also make provision for the cases when the patient is not
intent on quitting smoking, and then his decision must
be respected and the GP should abstain from any inter-
vention. Still, when the patient struggles on whether to
quit or not, the GP’s role in building or reinforcing mo-
tivation is crucial.
“[The GP] should treat everyone individually, be able
to relate to the patient’s disorders because we wouldn’t
care about something that is routine. If we keep on
always hearing the same things at the doctor’s, we’ll
stop listening. It depends on the way the doctor
approaches the patient, his ability to influence the
patient…” (P19)
What lies at the heart of this approach is the GP’s will-
ingness to know the patient better and improve the rela-
tionship with him, so that he can feel that what the GP
prescribes is only for him and results from the GP’s care
for his health. One of the patients, who was poorly moti-
vated to quit, emphasized that a tailored approach could
have a motivating impact on her:“If only there was such a tailored approach… If only I
felt that this is only for me…maybe I would consider it
[giving up smoking]” (P12)
Although the respondents would like their GP to bring
forth the topic of smoking cessation during the consult-
ation, even in the case when they are unprepared for
this, they also seem to have very specific expectations re-
garding the GP’s behavior. They do not want their GP to
be too aggressive. Such behavior can only deteriorate the
relationship between the GP and the patient, and does
not have a motivating influence on the patient’s decision
about smoking cessation. One of the smokers put it in
the following way:
“I wouldn’t like it [the GP’s approach] to be too
insistent… that GPs attack smokers… I’d like to know
that in the instance where I do want to quit, the
doctor will provide me with help, explain, answer the
questions and understand my situation… [The GP]
shouldn’t be too aggressive in raising smokers’
awareness… [he] should outline that this and that can
cause this and that…” (P17)
Access to information and reliable evidence on the harms
of tobacco smoking
When the issue of smoking is brought up during the
interview, the investigated patients would expect from
their GP reliable evidence confirming the harms of to-
bacco smoking, and some information detailing effective
methods of treatment.
Despite common knowledge that smoking is harmful,
it is the GP that was widely expected to provide reliable
information. The following examples highlight the role
of the GP, which involves providing access to evidence
and adequate information about the harms of tobacco
smoking:
“The doctor would have to present facts, either using
photos or tell stories from his professional career that
he used to have such patients and they gave up…
or that those who didn’t, for example, are already
dead.” (P7)
“If someone professionally explained to me why I
smoke, what makes me like smoking…” (P12)
Prescription of pharmacotherapy and other treatment
Likewise, in the case of therapy, the GP should be well
informed of widely accessible methods of treatment and
the means of their application. The investigated patients
expressed that they would be happy to obtain informa-
tion about successful treatment from their GP, especially
about effective medicines.
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when I asked her… I asked her because my friend gave
up smoking in this way. He got a prescription from his
GP… and he hasn’t been smoking for 2 months
already.” (P9)
Receiving effective treatment was very much expected
by the respondents. In particular, they would like to be
prescribed pills which would make them stop smoking.
This is illustrated by the following example:
“If I knew that there would be some treatment, that is,
that I would get medicines, I would be pleased to
benefit from that.” (P6)
But some smokers were open to any form of therapy,
not only effective pills.
“If my GP suggested some sort of therapy or something
like this, I think it would be great…” (P9)
Referral to specialists in smoking cessation
Some of the patients expected to be referred to specialist
stop-smoking services. This can be explained by greater
trust in treatments offered by a specialist in smoking
cessation, rather than by the GP. Another reason for this
expectation of referral was the opportunity to benefit
from psychological help. In the discussions, patients
underlined an important role for psychological support
in smoking cessation. This is illustrated by the following
examples:
“If there is a referral to a particular specialist and
there is an illness related to it [smoking], that smoking
has impact on… the specialist can somehow show it…
that because of that [smoking] it is so, and not
otherwise.” (P16)
“The psychologist could intervene… in order to make
us start to think differently about smoking and one’s
life.” (P18)
Discussion
This study presents smokers’ experiences and expecta-
tions related to the role of the GP in smoking cessation.
The main finding of our research is that the patients
expected their GP to intervene and bring up the topic of
smoking cessation. More specifically, in line with these
expectations the GP should adopt a tailored approach to
the patient and continue pursuing anti-nicotine inter-
ventions; or, if it is the patient’s will, the GP should not
mention the issue of smoking at all.
The respondents expected a more person-oriented ap-
proach rather than only a routine interview or routineconsultation. This is in agreement with other studies,
which indicated preferences for a more client-centered
approach in general practice [39]. In particular, irre-
spective of the purpose of the visit, patients’ preferences
show that they expect a GP who will have time for them,
listen to what they say and advise them on how to get
better or how to protect their health in the future
[39,40]. This study illustrates that the patients’ expecta-
tions also concern the process of smoking cessation.
This process must be more tailored, personalized, going
beyond standard procedures in order to bring positive
effect. A tailored approach facilitates doctor-patient
communication: GPs can learn about patients’ reasons
for smoking and adjust arguments to build their motiv-
ation. When the smoking patient decides to quit, in the
tailored approach, both the patient and the GP choose
the way of smoking cessation and a form of pharmaco-
therapy. In short, GPs need to establish a more satisfying
therapeutic relationship, individualize treatments to suit
the whole person and give up a routine consultation.
The patients also expected to be provided with reliable
information. It seems that good information plays a cru-
cial role in motivating them to take actions which lead
to a change in lifestyle. An important element in man-
aging smoking cessation, which is also expected by pa-
tients, is effective pharmacotherapy. The validity of these
expectations is corroborated by numerous studies, which
indicate that introducing pharmacotherapy increases the
number of patients permanently giving up smoking
[25-28,41].
This study has also shown how significant the GP’s ex-
ample is to those who contemplate quitting. Most par-
ticipants admitted they would feel more motivated to
stop smoking if their GP was a non-smoker. An interest-
ing finding was the patients’ experience of their GP as a
role model in smoking cessation. Notably, it was found
as particularly persuasive when the GP – the former
smoker – presented the problem of quitting tobacco
smoking not from a medical perspective, but from the
perspective of the smoker. GP’s sharing of his own ex-
perience seemed to have a modeling effect on the listen-
ing patient. To put it differently, the patient may have
possibly been more prone to emulate the GP’s behavior
and change his own lifestyle.
Furthermore, some of the patients would expect their
GP to firstly motivate them to quit smoking, and then
refer them to a specialist in smoking cessation. These
expectations are consistent with the results obtained in a
study by Wilson et al., in which patients often expected
their GP to start the treatment followed by a referral to
stop-smoking services [42]. In a different study, Murray
et al. showed that the identification of smokers in gen-
eral practice and subsequent referral to cessation ser-
vices increased the number of quit attempts [43]. Thus,
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cessation process. Although the investigated smokers
indicated the need for behavioral support, there aren’t
any widely available services for smoking cessation in
Poland.
In general, the patients’ experiences did not match
their expectations: the smokers rarely spoke with their
GP about quitting smoking and seldom got advice on
smoking cessation. This could be explained by a lack of
GP intervention for smoking cessation, but there may
also be little or no interest in seeking out help from the
patients themselves. The first problem has already
appeared in a study of Australian GPs, only a third of
whom reported providing cessation advice during every
routine consultation with a smoker [33]. The second is
partly corroborated by observations on Danish patients
and GPs presented in Guassora et al. [44]. Their study
revealed that smoking cessation advice shouldn’t be
given during every routine consultation with a smoker
especially when the purpose of the visit is not a
smoking-related problem. Such advice is not well re-
ceived by patients, although according to standing pro-
cedures, it should be given to smokers at every visit
[29-31]. Our findings also seem to suggest that it is diffi-
cult to establish one universal standard procedure for
lifestyle intervention. What is more, actions in this direc-
tion must cater for the patients’ needs and take account
of the way the healthcare system works. The very ex-
pectation that every time the smoker visits his GP the
problem of smoking will be discussed is unrealistic due
to lack of time. In a similar vein, bringing up the issue
of smoking cessation persistently during every consult-
ation, especially when it’s not connected with the pur-
pose of the visit, may not only irritate the patient, but
can also impede doctor-patient relationship. Nonethe-
less, it does not mean GPs can ignore anti-smoking
intervention altogether.
Furthermore, infrequent pursuit of help from a GP has
been reported by Hung et al., who conducted research
among recent quitters. It has been established that re-
cent quitters did not benefit from GPs’ advice as often as
from other methods, such as cold turkey, gradual reduc-
tion before quitting and nicotine replacement therapy
[45]. Also, a GP’s assistance has been perceived as less
helpful than the above-mentioned methods. One reason
for this is that patients rarely talked with their GP about
smoking cessation as they did not always realize that the
GP could help them. In addition, GPs did not intervene
at all or only routinely advised smoking patients to quit.
Likewise, in a study by Lambe and Collins, [41] GPs
focused mainly on fear appeals, without offering any
adequate support.
Patients’ ignorance about help in smoking cessation
that GPs can offer could also result from the fact thatthe issue of quitting is rarely brought up by the GP dur-
ing the visit. As some previous studies show, the major
reasons behind poor lifestyle interventions are insuffi-
cient time and no reimbursement for undertaking such
activities [41]. A similar situation can be found in
Poland, where GPs admit many patients and are paid for
treatment, not preventive, activities. It seems therefore
that the role of the GP in smoking cessation has not
been appreciated enough by patients. This is a missed
opportunity, especially if we take into account a study by
Murray et al., which shows that it is GP advice that acts
as the most important trigger for unplanned quit at-
tempts [46].
A limitation of this study is the relatively small num-
ber of interviews. Although we felt we had achieved sat-
uration, there might be selection biases operating, such
as an overrepresentation of patients with health prob-
lems due to the recruitment process conducted by the
GPs. On the other hand, the recruitment of participants
through the Institute of Sociology could have created a
selection biases in terms of an overrepresentation of
better-educated participants. Nevertheless, we still con-
sider our sample to be complex enough to identify pa-
tients’ expectations and experiences of how their GPs
deal with smoking cessation.
Another possible limitation are drawbacks resulting
from focus group discussions, if compared with the pres-
entation of experiences in individual interviews. These
may embrace, for example, the striving for conformity in
a group, which may prevent the participants from articu-
lating their real personal experiences. A certain limita-
tion in a group of patients who didn’t manage to stop
smoking may be an increased need to make their GP a
scapegoat for their failure to quit. Interaction among
focus group participants may reaffirm this conviction be-
cause the GP could always try to do more for the patient
to convince him to quit. This limitation is overcome to a
certain extent by research among those who succeeded
in smoking cessation and do not feel the need to look
for the scapegoat.
Finally, the problem of the division of responsibility
between the patient and the GP has not been addressed
since this topic was not very much discussed in the
groups.
Implications for practice and further research
An important implication from this study is the neces-
sity to bring the problem of smoking cessation to the
GP, and encourage its discussion during patients’ visits.
This requires, in turn, GP training in smoking cessation
intervention. Such training programs should result in a
situation where GPs act as facilitators and initiate a dis-
cussion about smoking cessation, provide a tailored ap-
proach to the patient, and use recent findings about the
Buczkowski et al. BMC Family Practice 2013, 14:159 Page 9 of 10
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Another important issue is the management of GPs’
work so that they can find time for smoking cessation
interventions. Even a GP who is well-prepared and con-
vinced of the righteousness of these interventions will
not undertake them if there’s no time. Changes in work
organization should limit GPs’ workload when it comes
to treatment activities, and there’s also a need for a shift
toward lifestyle interventions. In the case of Polish GPs
this would relate to a cut in the number of patients GPs
look after.
It is worth conducting future research to answer ques-
tions of what else may be the cause of GPs’ lack of inter-
ventions in smoking cessation, how to increase their
number, and how this is going to influence patients’ at-
tempts to quit smoking.Conclusion
While exploring the GP’s role in smoking cessation, the
study revealed a big discrepancy between patients’ ex-
pectations and experiences. The smokers’ experiences of
GPs’ aid in smoking cessation did not match their expec-
tations because the topic of smoking was rarely
discussed during visits and the doctor’s approach to the
patient was perceived by the patients as routine. The
participants of the study also observed that GPs had lit-
tle time for any interventions in smoking cessation in
their daily work and that the doctor-patient cooperation
in the process of giving up smoking is poor.
Patients expect their GP to actively participate in
smoking cessation. They also suggested that help should
be adjusted to meet the smoker’s individual needs. For
the majority of the investigated smokers this would
mean GPs taking the lead in initiating conversations
about smoking cessation, providing the patient with mo-
tivating information on quitting smoking, and assisting
in therapy implementation and management.
Although the patients would like their GP to be more
active in smoking cessation, to adopt a tailored ap-
proach, to provide them with evidence on the dangers of
smoking, and cater to their individual needs, the results
revealed that these desires are not often met. In sum-
mary, the GP should play a bigger role in smoking
cessation.Additional file
Additional file 1: Topic guide for focus group discussions.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
KB and LM are responsible for the design of the study with comments from
EP and SC. EP conducted the focus group interviews and transcribed them.
KB, LM and AS categorized the data and discussed it with EP and SC. KB, AS
and SC wrote the first draft of the manuscript and LM, EP commented on
draft versions of the manuscript. All authors read and approved the final
manuscript.Acknowledgements
The study was financially supported by Nicolaus Copernicus University in
Torun. The authors are grateful to all participating patients.
Author details
1Department of Family Medicine, Collegium Medicum, Nicolaus Copernicus
University, Sklodowskiej-Curie 9, 85-094, Bydgoszcz Torun, Poland.
2Department of Family Medicine and Community Nursing, Medical University
of Bialystok, Mieszka I 4B, 15-054, Bialystok, Poland. 3Sociology Institute,
Nicolaus Copernicus University, ul. Fosa Staromiejska 1a, 87-100, Torun,
Poland. 4Department of English, Nicolaus Copernicus University, ul. W.
Bojarskiego 1, 87-100, Torun, Poland.
Received: 16 November 2012 Accepted: 11 October 2013
Published: 20 October 2013References
1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr: Mortality from tobacco
in developed countries: indirect estimation from national vital statistics.
Lancet 1992, 339:1268–1278.
2. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M:
The preventable causes of death in the United States: comparative risk
assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med
2009, 6(4):e1000058. doi:10.1371/journal.pmed.1000058.
3. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF,
Froelicher ES, Goldstein MG, Healton CG: Treating Tobacco Use and
Dependence: 2008 Update. Rockville, MD, USA: US Department of Health and
Human Services, Public Health Service; 2008.
4. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M, The Comparative
Risk Assessment collaborating group: Causes of cancer in the world:
comparative risk assessment of nine behavioural and environmental risk
factors. Lancet 2005, 366:1784–1793.
5. Mathers CD, Loncar D: Projections of global mortality and burden of
disease from 2002 to 2030. PLoS Med 2006, 3(11):e442. doi:10.1371/journal.
pmed.0030442.
6. World Health Organization (WHO): WHO Report on the global tobacco
epidemic, 2011. Geneva, Switzerland: World Health Organization; 2011.
7. The current status of the tobacco epidemic in Poland. http://www.euro.
who.int/__data/assets/pdf_file/0006/68064/E92470.pdf.
8. Didkowska J, Wojciechowska U, Zatoński W: Spożycie tytoniu w Polsce w
latach 1923–1995. In Palenie tytoniu w Polsce: postawy, następstwa
zdrowotne i profilaktyka. Cz. I, Rozdz. 3. Wydanie drugie. Edited by Zatoński W,
Przewoźniak K. Warsaw, Poland: Central Oncology Institute; 1999:111–112.
9. Hyland A, Borland R, Li Q, Yong HH, McNeill A, Fong GT, O’Connor RJ,
Cummings KM: Individual-level predictors of cessation behaviours among
participants in the International Tobacco Control (ITC) Four Country
Survey. Tob Control 2006, 15(Suppl 3):iii83–iii94.
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M,
Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk
factors associated with myocardial infarction in 52 countries (the
INTERHEART study): case-control study. Lancet 2004, 364:937–952.
11. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham
JD: Five-hundred life-saving interventions and their cost-effectiveness.
Risk Anal 1995, 15:369–390.
12. Centers for Disease Control and Prevention (CDC): State-specific
prevalence of cigarette smoking and smokeless tobacco use among
adults- United States, 2009. MMWR Morb Mortal Wkly Rep 2010,
59:1400–1406.
13. Centers for Disease Control and Prevention (CDC): State-attributable
mortality, years of potential life lost and productivity losses- United
States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008, 57:1226–1228.
Buczkowski et al. BMC Family Practice 2013, 14:159 Page 10 of 10
http://www.biomedcentral.com/1471-2296/14/15914. Act of amendment of the act on protection of health against the
consequences of consumption of tobacco and tobacco products, April 8,
2010. http://isap.sejm.gov.pl/DetailsServlet?id=WDU20100810529.
15. Tobacco control database for the WHO European Region. http://data.
euro.who.int/Tobacco/Sites/Legislation.aspx?legislatureID=40.
16. Tobacco taxes in Poland. http://global.tobaccofreekids.org/files/pdfs/en/
Poland_tobacco_taxes_summary_en.pdf.
17. Health and health care in 2011. http://www.stat.gov.pl/cps/rde/xbcr/gus/
zo_zdrowie_i_ochrona_zdrowia_w_2011.pdf.
18. Bujnowska-Fedak M, Sapilak BJ, Steciwko A: Epidemiologia schorzeń i
struktura zachorowań w praktyce lekarza rodzinnego. Family Medicine
and Primary Care Review 2011, 13:135–140.
19. Czachowski S, Pawlikowska T: ‘These reforms killed me’: doctors’
perceptions of family medicine during the transition from communism
to capitalism. Fam Pract 2011, 28:437–443.
20. Global health survey. Experience & perception in 28 countries.
http://www.irisnetwork.org/Publications%20Downloads/BAN/BAN_IRIS_%
20Global_%20Health_%20Survey.pdf.
21. Raw M, McNeill A, Coleman T: Lessons from the English smoking
treatment services. Addiction 2005, 2:84–91.
22. Sieminska A, Buczkowski K, Jassem E, Lewandowska K, Ucinska R,
Chelminska M: Patterns of motivations and ways of quitting smoking
among Polish smokers: a questionnaire study. BMC Public Health 2008,
8:274.
23. Medbø A, Melbye H, Rudebeck CE: “I did not intend to stop. I just could
not stand cigarettes any more.” A qualitative interview study of smoking
cessation among the elderly. BMC Fam Pract 2011, 31:12–42.
24. Katanoda K, Levy DT, Nakamura M, Hagimoto A, Oshima A: Modeling the
effect of disseminating brief intervention for smoking cessation at
medical facilities in Japan: a simulation study. Cancer Causes Control 2012,
23:929–939.
25. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster
T: Nicotine replacement therapy for smoking cessation. Cochrane
Database Sys Rev 2012, 11, CD000146.
26. Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation.
Cochrane Database Sys Rev 2007, 1, CD000031.
27. Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for
smoking cessation. Cochrane Database Sys Rev 2012, 4, CD006103.
28. Aubin HJ, Luquiens A, Berlin I, Pharmacotherapy for smoking cessation:
Pharmacological principles and clinical practice. Br J Clin Pharmacol 2013,
15. 10.1111/bcp.12116. [Epub ahead of print].
29. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C,
Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G,
Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M,
Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad
F, European Association for Cardiovascular Prevention & Rehabilitation
(EACPR); ESC Committee for Practice Guidelines (CPG): European
Guidelines on cardiovascular disease prevention in clinical practice
(version 2012). The Fifth Joint Task Force of the European Society of
Cardiology and Other Societies on Cardiovascular Disease Prevention in
Clinical Practice (constituted by representatives of nine societies and by
invited experts). Eur Heart J 2012, 33:1635–1701.
30. Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and
Dependence: 2008 Update. Rockville (MD): US Department of Health and
Human Services; 2008. Available from: http://www.ncbi.nlm.nih.gov/books/
NBK63952/.
31. Guidelines for anti-smoking intervention. http://www.klrwp.pl/file/
zasady_interwencji_antytytoniowej.pdf.
32. Aveyard P, West R: Managing smoking cessation. BMJ 2007, 335:37–41.
33. Young JM, Ward JE: Implementing guidelines for smoking cessation
advice in Australian general practice: opinions, current practices,
readiness to change and perceived barriers. Fam Pract 2001, 18:14–20.
34. Szatkowski L, Lewis S, McNeill A, Coleman T: Is smoking status routinely
recorded when patients register with a new GP? Fam Pract 2010, 27:673–675.
35. Sandelowski M: Whatever happened to qualitative description? Res Nurs
Health 2000, 23:334–340.
36. Graneheim UH, Lundman B: Qualitative content analysis in nursing
research: concepts, procedures and measures to achieve
trustworthiness. Nurse Educ Today 2004, 24:105–112.
37. Ledwith F: Guidelines for the Conduct of Tobacco Smoking Surveys of the
General Population. Geneva, Switzerland: WHO/SMO/83.4; 1983.38. World Health Organization: Guidelines for controlling and monitoring the
tobacco epidemic. Geneva: WHO; 1998:10–76.
39. Little P, Everitt H, Williamson I, Warner G, Moore M, Gould C, Ferrier K, Payne
S: Preferences of patients for patient centred approach to consultation
in primary care: observational study. BMJ 2001, 322:468–472.
40. Rakel D: The salutogenesis oriented session: creating space and time for
healing in primary care. Explore 2008, 4:42–47.
41. Lambe B, Collins C: A qualitative study of lifestyle counselling in general
practice in Ireland. Fam Pract 2010, 27:219–223.
42. Wilson A, Agarwal S, Bonas S, Murtagh G, Coleman T, Taub N, Chernova J:
Management of smokers motivated to quit: a qualitative study of
smokers and GPs. Fam Pract 2010, 27:404–409.
43. Murray RL, Coleman T, Antoniak M, Stocks J, Fergus A, Britton J, Lewis SA:
The effect of proactively identifying smokers and offering smoking
cessation support in primary care populations: a cluster-randomized
trial. Addiction 2008, 103:998–1006.
44. Guassora AD, Baarts C: Smoking cessation advice in consultations with
health problems not related to smoking? Relevance criteria in Danish
general practice consultations. Scand J Prim Health Care 2010, 28:221–228.
45. Hung WT, Dunlop SM, Perez D, Cotter T: Use and perceived helpfulness of
smoking cessation methods: results from a population survey of recent
quitters. BMC Public Health 2011, 11:592.
46. Murray RL, Lewis SA, Coleman T, Britton J, McNeill A: Unplanned attempts
to quit smoking: missed opportunities for health promotion? Addiction
2009, 11:1901–1909.
doi:10.1186/1471-2296-14-159
Cite this article as: Buczkowski et al.: “What kind of general practitioner
do I need for smoking cessation?” Results from a qualitative study in
Poland. BMC Family Practice 2013 14:159.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
